FDA approves standard freezing temperatures for Pfizer vaccines

The US Food and Drug Administration (FDA) on Thursday approved storage and transportation of the COVID-19 vaccine developed by Pfizer and BioNTech at standard freezer temperatures for up to two weeks instead of ultra-cold conditions, Reuters reported.

The approval comes a week after the companies asked the US health regulator to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially allowing it to be kept in pharmacy freezers.